MarginsXMarginsX
Home › Markets › Health Care › AZR

Azora Therapeutics Inc. (AZR)

AZR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.81
-6.85% on the day
Market cap
$54.4M
Micro cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerAZR on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2018
SEC CIK0001513525
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue in SEC XBRL data for this filer.

Warning signs

Cash runway
16.6 months
$22.0M cash at September 30, 2026
Share count, 1 year
+1388.9%
2025-11-07 to 2026-11-09 · +29223.8% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$106K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the financial statements are issued."
10-Q 2026-11-12
Cash and burn$22.0M cash; operating cash flow -$4.0M a quarter.Report 2026-09-30
Shares outstanding14,286,311 (2026-11-09); 23,987,587 a year earlier; 1,217,981 three years earlier. 1y figure adjusted for splits (1-for-25 overall); 3y figure adjusted for splits (1-for-25 overall).Cover page 2026-11-09
Reverse splits, 3 years1; latest 1-for-25 on 2026-02-06Source 2026-02-06
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-12-19
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-08-21
AuditorCBIZ CPAs P.C., Marlton, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-05-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $106K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$64.6M-$6.6M$22.0MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$52.0M-$6.4M$28.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$2.0M-$1.6M$4.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$2.0M-$1.3M$5.9MNo debt tagsNeeds four quarters10-K 2026-03-05
Q3 2025
2025-09-30
Not filed-$1.8M-$1.8M$4.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$2.0M-$1.7M$5.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$2.2M-$1.6M$2.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
Not filed-$2.1M-$1.5M$3.8MNo debt tagsNeeds four quarters10-K 2026-03-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
S-32026-08-28
Latest annual report
ANNUAL REPORT
10-K2026-03-05
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-11-12
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-10-16

Source: SEC EDGAR submissions feed, 582 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.2%
1 month+24.3%
3 months-6.8%
Year to date-25.6%
1 year-48.9%
From 52-week high-50.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
INCRIntercure Ltd.$3.63-4.22%$54.5M
XLOXilio Therapeutics Inc.$7.70-3.08%$54.4M
CINGCingulate Inc.$3.75-12.79%$54.5M
HRTXHeron Therapeutics Inc.$0.2843-8.44%$54.1M
VRCAVerrica Pharmaceuticals Inc.$3.20-10.11%$55.0M
SPROSpero Therapeutics Inc.$0.9464-5.35%$55.1M
TNXPTonix Pharmaceuticals Holding Corp.$2.88-4.32%$56.0M
CLNNClene Inc.$3.66-6.63%$52.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier